Agneta Nordberg, MD PhD - Publications

Affiliations: 
Neurobiology, Care Sciences and Society Karolinska Institute, Stockholm, Sweden 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=86
Website:
http://ki.se/ki/jsp/polopoly.jsp?d=34701&a=101537&l=en

396 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Sobek J, Li J, Combes BF, Gerez JA, Henrich MT, Geibl FF, Nilsson PR, Shi K, Rominger A, Oertel WH, Nitsch RM, Nordberg A, Ågren H, Ni R. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38953933 DOI: 10.1007/s00259-024-06806-7  0.613
2024 Mastenbroek SE, Sala A, Vállez García D, Shekari M, Salvadó G, Lorenzini L, Pieperhoff L, Wink AM, Lopes Alves I, Wolz R, Ritchie C, Boada M, Visser PJ, Bucci M, Farrar G, ... ... Nordberg AK, et al. Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity. Neurology. 103: e209419. PMID 38862136 DOI: 10.1212/WNL.0000000000209419  0.398
2024 Nordberg A. Insights into the progression of genetic Alzheimer's disease from tau PET. The Lancet. Neurology. 23: 453-454. PMID 38631755 DOI: 10.1016/S1474-4422(24)00124-8  0.376
2024 Bollack A, Collij LE, García DV, Shekari M, Altomare D, Payoux P, Dubois B, Grau-Rivera O, Boada M, Marquié M, Nordberg A, Walker Z, Scheltens P, Schöll M, Wolz R, et al. Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38574374 DOI: 10.1002/alz.13761  0.574
2024 Hönig M, Altomare D, Caprioglio C, Collij L, Barkhof F, Van Berckel B, Scheltens P, Farrar G, Battle MR, Theis H, Giehl K, Bischof GN, Garibotto V, Molinuevo JLL, Grau-Rivera O, ... ... Nordberg AK, et al. Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease. Neurology. 102: e208053. PMID 38377442 DOI: 10.1212/WNL.0000000000208053  0.311
2023 Fontana IC, Kumar A, Okamura N, Nordberg A. Multitracer Approach to Understanding the Complexity of Reactive Astrogliosis in Alzheimer's Brains. Acs Chemical Neuroscience. PMID 38133820 DOI: 10.1021/acschemneuro.3c00646  0.336
2023 Bader I, Bader I, Lopes Alves I, Vállez García D, Vellas B, Dubois B, Boada M, Marquié M, Altomare D, Scheltens P, Vandenberghe R, Hanseeuw B, Schöll M, Frisoni GB, Jessen F, ... Nordberg A, et al. Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study. Alzheimer's Research & Therapy. 15: 189. PMID 37919783 DOI: 10.1186/s13195-023-01332-4  0.632
2023 Chiotis K, Johansson C, Rodriguez-Vieitez E, Ashton NJ, Blennow K, Zetterberg H, Graff C, Nordberg A. Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP. Molecular Neurodegeneration. 18: 60. PMID 37697307 DOI: 10.1186/s13024-023-00647-y  0.7
2023 Li J, Kumar A, Långström B, Nordberg A, Ågren H. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils. Acs Chemical Neuroscience. PMID 37639522 DOI: 10.1021/acschemneuro.3c00437  0.304
2023 Bucci M, Bluma M, Savitcheva I, Ashton NJ, Chiotis K, Matton A, Kivipelto M, Di Molfetta G, Blennow K, Zetterberg H, Nordberg A. Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic. Translational Psychiatry. 13: 268. PMID 37491358 DOI: 10.1038/s41398-023-02558-4  0.73
2023 Fontana IC, Scarpa M, Malarte ML, Rocha FM, Ausellé-Bosch S, Bluma M, Bucci M, Chiotis K, Kumar A, Nordberg A. Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective. Cells. 12. PMID 37296589 DOI: 10.3390/cells12111469  0.751
2023 Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, ... ... Nordberg A, et al. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial. Jama Neurology. PMID 37155177 DOI: 10.1001/jamaneurol.2023.0997  0.703
2023 Almkvist O, Nordberg A. A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer's disease. Alzheimer's Research & Therapy. 15: 89. PMID 37131241 DOI: 10.1186/s13195-023-01231-8  0.574
2023 Oeckl P, Bluma M, Bucci M, Halbgebauer S, Chiotis K, Sandebring-Matton A, Ashton NJ, Molfetta GD, Grötschel L, Kivipelto M, Blennow K, Zetterberg H, Savitcheva I, Nordberg A, Otto M. Blood β-synuclein is related to amyloid PET positivity in memory clinic patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37052206 DOI: 10.1002/alz.13046  0.684
2023 Fontana IC, Kumar A, Nordberg A. The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease. Nature Reviews. Neurology. PMID 36977843 DOI: 10.1038/s41582-023-00792-4  0.375
2023 Malarte ML, Gillberg PG, Kumar A, Bogdanovic N, Lemoine L, Nordberg A. Correction: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains. Molecular Psychiatry. PMID 36890300 DOI: 10.1038/s41380-023-02021-2  0.399
2023 Mohanty R, Ferreira D, Nordberg A, Westman E. Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity. Alzheimer's Research & Therapy. 15: 37. PMID 36814346 DOI: 10.1186/s13195-023-01173-1  0.407
2023 Collij LE, Farrar G, Valléz García D, Bader I, Shekari M, Lorenzini L, Pemberton H, Altomare D, Pla S, Loor M, Markiewicz P, Yaqub M, Buckley C, Frisoni GB, Nordberg A, et al. The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact. Frontiers in Neurology. 13: 1063598. PMID 36761917 DOI: 10.3389/fneur.2022.1063598  0.668
2022 Malarte ML, Gillberg PG, Kumar A, Bogdanovic N, Lemoine L, Nordberg A. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains. Molecular Psychiatry. PMID 36447011 DOI: 10.1038/s41380-022-01875-2  0.34
2022 Ferreira D, Mohanty R, Murray ME, Nordberg A, Kantarci K, Westman E. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review. Acta Neuropathologica Communications. 10: 166. PMID 36376963 DOI: 10.1186/s40478-022-01471-z  0.395
2022 Altomare D, Collij L, Caprioglio C, Scheltens P, van Berckel BNM, Alves IL, Berkhof J, de Gier Y, Garibotto V, Moro C, Poitrine L, Delrieu J, Payoux P, Saint-Aubert L, Molinuevo JL, ... ... Nordberg A, et al. Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35715930 DOI: 10.1002/alz.12696  0.673
2022 Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Nordberg A, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216  0.538
2021 Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A. Lack of fibrillar amyloid plaques but hypometabolism and astrogliosis in autosomal dominant variant AßPParc Alzheimer's disease. Molecular Psychiatry. 26: 5471. PMID 35027661 DOI: 10.1038/s41380-021-01270-3  0.357
2021 Kumar A, Fontana IC, Nordberg A. Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease. Journal of Neurochemistry. PMID 34931315 DOI: 10.1111/jnc.15565  0.4
2021 Bucci M, Chiotis K, Nordberg A. Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Molecular Psychiatry. PMID 34593971 DOI: 10.1038/s41380-021-01263-2  0.745
2021 Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter M, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, ... Nordberg A, et al. Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34546388 DOI: 10.1007/s00259-021-05549-z  0.666
2021 Colato E, Chiotis K, Ferreira D, Mazrina MS, Lemoine L, Mohanty R, Westman E, Nordberg A, Rodriguez-Vieitez E. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 34511502 DOI: 10.3233/JAD-210614  0.768
2021 Murugan NA, Nordberg A, Ågren H. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy. Acs Chemical Neuroscience. 12: 2437-2447. PMID 34152739 DOI: 10.1021/acschemneuro.0c00340  0.326
2021 Almkvist O, Brüggen K, Nordberg A. Subcortical and Cortical Regions of Amyloid-β Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients. Journal of Alzheimer's Disease : Jad. PMID 33967046 DOI: 10.3233/JAD-201612  0.591
2021 Bellaver B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, Pellerin L, Rosa-Neto P, Leffa DT, Zimmer ER. Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis. Neurology. PMID 33952650 DOI: 10.1212/WNL.0000000000012109  0.649
2021 Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet. Neurology. PMID 33933186 DOI: 10.1016/S1474-4422(21)00066-1  0.35
2021 Kumar A, Koistinen NA, Malarte ML, Nennesmo I, Ingelsson M, Ghetti B, Lemoine L, Nordberg A. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain. Molecular Psychiatry. PMID 33888872 DOI: 10.1038/s41380-021-01101-5  0.349
2021 Bucci M, Savitcheva I, Farrar G, Salvadó G, Collij L, Doré V, Gispert JD, Gunn R, Hanseeuw B, Hansson O, Shekari M, Lhommel R, Molinuevo JL, Rowe C, Sur C, ... ... Nordberg A, et al. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [F]flutemetamol amyloid PET images. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33844055 DOI: 10.1007/s00259-021-05311-5  0.316
2021 Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue. Journal of Alzheimer's Disease : Jad. PMID 33749648 DOI: 10.3233/JAD-201344  0.708
2021 Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A. Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33723628 DOI: 10.1007/s00259-021-05277-4  0.733
2021 Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter MA, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, ... Nordberg A, et al. The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33688996 DOI: 10.1007/s00259-020-05120-2  0.688
2021 Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, Giovanni BFG, Garibotto V, Drzezga A. Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33590274 DOI: 10.1007/s00259-020-05156-4  0.392
2021 Villemagne VL, Barkhof F, Garibotto V, Landau SM, Nordberg A, van Berckel BNM. Molecular Imaging Approaches in Dementia. Radiology. 200028. PMID 33464184 DOI: 10.1148/radiol.2020200028  0.341
2020 Mohanty R, Mårtensson G, Poulakis K, Muehlboeck JS, Rodriguez-Vieitez E, Chiotis K, Grothe MJ, Nordberg A, Ferreira D, Westman E. Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization. Brain Communications. 2: fcaa192. PMID 33305264 DOI: 10.1093/braincomms/fcaa192  0.699
2020 Sala A, Nordberg A, Rodriguez-Vieitez E. Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity. Molecular Psychiatry. PMID 33303945 DOI: 10.1038/s41380-020-00950-w  0.358
2020 Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, ... ... Nordberg A, et al. Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962. PMID 33098804 DOI: 10.1016/S1474-4422(20)30314-8  0.366
2020 Smailovic U, Koenig T, Savitcheva I, Chiotis K, Nordberg A, Blennow K, Winblad B, Jelic V. Regional disconnection in Alzheimer dementia and amyloid positive MCI: Association of EEG functional connectivity and brain glucose metabolism. Brain Connectivity. PMID 33073602 DOI: 10.1089/brain.2020.0785  0.739
2020 Malarte ML, Nordberg A, Lemoine L. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32970217 DOI: 10.1007/s00259-020-05035-y  0.424
2020 Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, Delrieu J, Dubois B, Kivipelto M, Nordberg A, Schott JM, van der Flier WM, Vellas B, Jessen F, Scheltens P, et al. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32815289 DOI: 10.1002/Alz.12132  0.357
2020 Perini G, Rodriguez-Vieitez E, Kadir A, Sala A, Savitcheva I, Nordberg A. Clinical impact of F-FDG-PET among memory clinic patients with uncertain diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32734458 DOI: 10.1007/S00259-020-04969-7  0.37
2020 Chiotis K, Savitcheva I, Poulakis K, Saint-Aubert L, Wall A, Antoni G, Nordberg A. [F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease. Molecular Psychiatry. PMID 32616831 DOI: 10.1038/S41380-020-0815-4  0.829
2020 Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9. Molecular Psychiatry. PMID 32581318 DOI: 10.1038/S41380-020-0817-2  0.719
2020 Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, Lleó A, Westman E, Graff C, Fortea J, Nordberg A. Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease. Neurology. PMID 32291295 DOI: 10.1212/Wnl.0000000000009405  0.636
2020 Kuang G, Murugan NA, Zhou Y, Nordberg A, Agren H. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils. Acs Chemical Neuroscience. PMID 32069017 DOI: 10.1021/Acschemneuro.9B00578  0.386
2020 Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis. Neurology. PMID 32047067 DOI: 10.1212/WNL.0000000000009058  0.314
2019 Karami A, Eriksdotter M, Kadir A, Almkvist O, Nordberg A, Darreh-Shori T. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease. Frontiers in Molecular Neuroscience. 12: 239. PMID 31680850 DOI: 10.3389/Fnmol.2019.00239  0.62
2019 Lana E, Gellerbring A, Jung S, Nordberg A, Unger Lithner C, Darreh-Shori T. Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype. Frontiers in Molecular Neuroscience. 12: 176. PMID 31417354 DOI: 10.3389/Fnmol.2019.00176  0.449
2019 Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Nordberg A, Viitanen M, Lannfelt L, Graff C. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes. Neurobiology of Aging. 82: 40-47. PMID 31386938 DOI: 10.1016/J.Neurobiolaging.2019.06.010  0.565
2019 Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, ... ... Nordberg A, et al. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology. PMID 31267207 DOI: 10.1007/S00415-019-09441-7  0.748
2019 Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31230910 DOI: 10.1016/J.Jalz.2019.02.004  0.421
2019 Murugan NA, Chiotis K, Rodriguez-Vieitez E, Lemoine L, Ågren H, Nordberg A. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30919054 DOI: 10.1007/S00259-019-04305-8  0.69
2019 Leuzy A, Savitcheva I, Chiotis K, Lilja J, Andersen P, Bogdanovic N, Jelic V, Nordberg A. Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30915522 DOI: 10.1007/S00259-019-04297-5  0.72
2019 Jonasson M, Wall A, Chiotis K, Leuzy A, Eriksson J, Antoni G, Nordberg A, Lubberink M. Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [F]THK5317 PET. Neuroimage. Clinical. 22: 101681. PMID 30710871 DOI: 10.1016/J.Nicl.2019.101681  0.719
2019 Zou R, Kuang G, Agren H, Nordberg A, Långström B, Tu Y. Free Energy Profile for Penetration of Pittsburgh Compound-B into the Amyloid β Fibril. Acs Chemical Neuroscience. PMID 30698013 DOI: 10.1021/Acschemneuro.8B00662  0.38
2019 Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Molecular Psychiatry. PMID 30635637 DOI: 10.1038/S41380-018-0342-8  0.784
2019 Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine. PMID 30611668 DOI: 10.1016/J.Molmed.2018.11.006  0.69
2019 Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K, Nordberg A. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30610252 DOI: 10.1007/S00259-018-4242-6  0.823
2019 Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 46: 348-356. PMID 30515545 DOI: 10.1007/S00259-018-4217-7  0.802
2019 Darreh-Shori T, Kumar R, Kumar A, Murumkar P, Nag S, Jia Z, Arakawa R, Leuzy A, Lemoine L, Nordberg A, Yadav MR, Halldin C, Långström B. LIGANDS OF THE CORE ACETYLCHOLINE BIOSYNTHESIZING ENZYME, CHOLINE ACETYLTRANSFERASE, AS NOVEL AND POTENTIAL THERAPEUTIC AGENTS AND IN VIVO PET TRACERS FOR EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P1630. DOI: 10.1016/J.Jalz.2019.06.4869  0.36
2018 Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, ... Nordberg A, et al. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130. PMID 30477568 DOI: 10.1186/S40478-018-0624-Z  0.483
2018 Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, ... ... Nordberg A, et al. AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30339801 DOI: 10.1016/J.Jalz.2018.09.003  0.416
2018 Oliveira F, Leuzy A, Castelhano J, Chiotis K, Hasselbalch SG, Rinne J, Mendonça A, Otto M, Lleó A, Santana I, Johansson J, Anderl-Straub S, Arnim C, Beer A, Blesa R, ... ... Nordberg A, et al. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species. Neuroimage. Clinical. 20: 603-610. PMID 30186764 DOI: 10.1016/J.Nicl.2018.08.023  0.767
2018 Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, Shams M, Aspelin P, Kristoffersen-Wiberg M, Nordberg A, Wahlund LO, Westman E. The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiology of Aging. 70: 18-29. PMID 29935417 DOI: 10.1016/J.Neurobiolaging.2018.05.028  0.476
2018 Lilja J, Leuzy A, Chiotis K, Savitcheva I, Sörensen J, Nordberg A. Spatial normalization of [F]flutemetamol PET images utilizing an adaptive principal components template. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29903930 DOI: 10.2967/Jnumed.118.207811  0.706
2018 Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 232-236. PMID 29780868 DOI: 10.1016/J.Dadm.2018.01.007  0.742
2018 Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29752516 DOI: 10.1007/S00259-018-4012-5  0.785
2018 Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. Alzheimer's Research & Therapy. 10: 45. PMID 29747683 DOI: 10.1186/S13195-018-0374-Y  0.768
2018 Murugan NA, Nordberg A, Ågren H. Different PET tau tracers bind to multiple binding sites on the tau fibril : Insight from computational modeling. Acs Chemical Neuroscience. PMID 29630333 DOI: 10.1021/Acschemneuro.8B00093  0.328
2018 Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, ... ... Nordberg A, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009  0.565
2018 Rodriguez-Vieitez E, Nordberg A. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Methods in Molecular Biology (Clifton, N.J.). 1750: 231-251. PMID 29512077 DOI: 10.1007/978-1-4939-7704-8_16  0.532
2018 Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M. Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29419480 DOI: 10.2967/Jnumed.117.201632  0.714
2017 Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29268078 DOI: 10.1016/J.Jalz.2017.11.008  0.825
2017 Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains. Alzheimer's Research & Therapy. 9: 96. PMID 29229003 DOI: 10.1186/S13195-017-0325-Z  0.411
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Nordberg A, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391  0.574
2017 Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H. Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers- Insight from Molecular Modeling Studies. Acs Chemical Neuroscience. PMID 28898051 DOI: 10.1021/Acschemneuro.7B00215  0.428
2017 Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X  0.798
2017 Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's Disease : Jad. 59: 603-614. PMID 28671117 DOI: 10.3233/Jad-170158  0.799
2017 Heurling K, Leuzy A, Jonasson M, Frick A, Zimmer ER, Nordberg A, Lubberink M. Quantitative positron emission tomography in brain research. Brain Research. PMID 28652218 DOI: 10.1016/J.Brainres.2017.06.022  0.43
2017 Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Molecular Psychiatry. 23: 1666-1673. PMID 28507319 DOI: 10.1038/Mp.2017.108  0.851
2017 Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography. Scientific Reports. 7: 45496. PMID 28374768 DOI: 10.1038/Srep45496  0.716
2017 Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 285-295. PMID 28341066 DOI: 10.1016/J.Jalz.2016.09.009  0.46
2017 Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 274-284. PMID 28341065 DOI: 10.1016/J.Jalz.2016.09.008  0.442
2017 Chiotis K, Saint-Aubert L, Boccardi M, Gietl A, Picco A, Varrone A, Garibotto V, Herholz K, Nobili F, Nordberg A. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 214-227. PMID 28317650 DOI: 10.1016/J.Neurobiolaging.2016.07.012  0.825
2017 Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A, Nobili F, Ratib O. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 183-195. PMID 28317648 DOI: 10.1016/J.Neurobiolaging.2016.03.033  0.461
2017 Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging: present and future directions. Molecular Neurodegeneration. 12: 19. PMID 28219440 DOI: 10.1186/S13024-017-0162-3  0.839
2017 Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain : a Journal of Neurology. PMID 28087578 DOI: 10.1093/Brain/Aww339  0.709
2017 Kuang G, Zhou Y, Zou R, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y. Characterization of the binding mode of the PET tracer [18F]ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor Rsc Advances. 7: 19787-19793. DOI: 10.1039/C7Ra00496F  0.319
2017 Frisoni GB, Barkhof F, Farrar G, Raffa N, Gismondi R, Schmidt ME, Berkhof J, Boccardi M, Walker Z, Scheltens P, Schott JM, Molinuevo JL, Vellas B, Jessen F, Nordberg A, et al. THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET Alzheimer's & Dementia. 13: P1523. DOI: 10.1016/J.Jalz.2017.07.653  0.393
2017 Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [IC-P-178]: HEAD-TO-HEAD IN VIVO COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11 C]THK5351 VERSUS [11 C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P133-P133. DOI: 10.1016/J.Jalz.2017.06.2553  0.791
2017 Leuzy A, Chiotis K, Jelic V, Andersen P, Friman J, Lilja J, Savitcheva I, Nordberg A. Investigating The Clinical Impact Of [18F]Flutemetamol Pet In A Tertiary Memory Clinic Setting In Patients With Uncertain Diagnosis Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2288  0.682
2017 Lemoine L, Gillberg P, Svedberg M, Stepanov V, Nag S, Tian H, Higuchi M, Halldin C, Nordberg A. [P4-274]: COMPARISON OF BINDING PROPERTIES OF THK5117, THK5351, PBB3 AND T807 IN AUTOPSIES OF ALZHEIMER DISEASE CASES Alzheimer's & Dementia. 13: P1390-P1390. DOI: 10.1016/J.Jalz.2017.06.2143  0.348
2017 Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [P2-366]: HEAD-TO-HEAD IN VIVO COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11 C]THK5351 VERSUS [11 C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P765-P765. DOI: 10.1016/j.jalz.2017.06.1021  0.613
2016 Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C. Development of [(11)C]/[(3)H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand. Nuclear Medicine and Biology. 46: 50-53. PMID 28013122 DOI: 10.1016/J.Nucmedbio.2016.12.004  0.42
2016 Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693181 DOI: 10.1016/J.Jalz.2016.08.006  0.729
2016 Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A. Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 38. PMID 27683159 DOI: 10.1186/S13195-016-0204-Z  0.848
2016 Natarajan AM, Halldin C, Nordberg A, Långström B, Ågren H. The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid Specific Tracers. The Journal of Physical Chemistry Letters. PMID 27498616 DOI: 10.1021/Acs.Jpclett.6B01586  0.341
2016 Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1316-22. PMID 27481605 DOI: 10.2967/Jnumed.116.174615  0.383
2016 Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, ... ... Nordberg A, et al. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study. Brain : a Journal of Neurology. PMID 27401520 DOI: 10.1093/Brain/Aww160  0.714
2016 Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, ... Nordberg A, et al. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimer's Research & Therapy. 8: 30. PMID 27389402 DOI: 10.1186/S13195-016-0195-9  0.563
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Wall A, Nordberg A. Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27107028 DOI: 10.1177/0271678X16645593  0.821
2016 Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1686-99. PMID 26996778 DOI: 10.1007/S00259-016-3363-Z  0.846
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, ... ... Nordberg A, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.421
2016 Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912447 DOI: 10.2967/Jnumed.115.168732  0.814
2016 Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 26813969 DOI: 10.1093/Brain/Awv404  0.831
2016 Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson JP, Sörensen J, Antoni G, Nordberg A, Lubberink M. Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26795290 DOI: 10.2967/Jnumed.115.158519  0.84
2016 Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. 43: 362-73. PMID 26440450 DOI: 10.1007/S00259-015-3208-1  0.442
2016 Chiotis K, Saint-Aubert L, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau pet imaging in neurodegenerative tauopathies – a multimodal paradigm Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.125  0.812
2016 Nordberg A. Molecular PET imaging as correlates to drug response Neurobiology of Aging. 39: S23-S24. DOI: 10.1016/J.Neurobiolaging.2016.01.105  0.32
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Nordberg A. Comparison of Early-Phase (S)-[18F]THK5117 and [11C]PIB PET imaging to assess brain perfusion in Alzheimer’s disease Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.095  0.817
2016 Nordberg A. Longitudinal studies of regional tau deposition in brain by PET Neurobiology of Aging. 39: S19. DOI: 10.1016/J.Neurobiolaging.2016.01.087  0.418
2016 Leuzy A, Chiotis K, Pannee J, Hasselbalch S, Rinne J, Castelo-Branco M, Mendonca A, Santana I, Bisa AL, Johansson J, Otto M, Portelius E, Zetterberg H, Blennow K, Nordberg A. Improved concordance between [11C]PIB PET and CSF Aβ42 using Aβ42/Aβ40: findings from a multicentre European memory clinic population Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.084  0.725
2016 Lemoine L, Ingelsson M, Nennesmo I, Gillberg P, Nordberg A. In vitro characterization of fibrillar amyloid, tau deposits, and activated astrocytes in Arctic APP and sporadic Alzheimer's disease brain using, 3H-PIB and 3H-THK5117 and 3H-Deprenyl in comparison to immunostaining Neurobiology of Aging. 39: S15. DOI: 10.1016/J.Neurobiolaging.2016.01.073  0.388
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Almkvist O, Wall A, Nordberg A. Early-Phase [11C]Pib Pet Is Comparable To [18F]Fdg Pet As A Marker Of Disease Progression In Alzheimer'S Disease Alzheimers & Dementia. 12: 1171. DOI: 10.1016/J.Jalz.2016.07.094  0.833
2016 Lemoine L, Ingelsson M, Nennesmo I, Gillberg P, Nordberg A. P1-105: In vitro Characterization of Fibrillar Amyloid, TAU Deposition, and Activated Astrocytes in Arctic Alzheimer's Disease Brain in Comparison With Sporadic Alzheimer's Disease Brain Using 3H-PIB, 3H-THK5117 and 3H-DEPRENYL Alzheimer's & Dementia. 12: P442-P442. DOI: 10.1016/J.Jalz.2016.06.853  0.423
2016 Nordberg A, Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Almkvist O, Wall A, Antoni G. Longitudinal Changes In Regional Tau Deposition In Alzheimer'S Disease And Other Tauopathies Measured By [18F]-Tkh5317 Pet In A Multi-Tracer Design Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.645  0.833
2016 Lemoine L, Ingelsson M, Nennesmo I, Gillberg P, Nordberg A. IC-P-170: In Vitro Characterization of Fibrillar Amyloid, TAU Deposition, and Activated Astrocytes in Arctic AD Brain in Comparison With Sporadic AD Brain Using 3H-PIB, 3H-THK5117 and 3H-Deprenyl Alzheimer's & Dementia. 12: P124-P124. DOI: 10.1016/J.Jalz.2016.06.201  0.391
2016 Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Wall A, Antoni G, Nordberg A. Tau Pet Imaging In Non-Alzheimer’S Disease Dementia: A Multimodal Paradigm Alzheimers & Dementia. 12: 137. DOI: 10.1016/J.Jalz.2016.06.1925  0.828
2016 Saint-Aubert L, Chiotis K, Wall A, Almkvist O, Nordberg A. P1-306: Association Between in Vivo TAU Deposition Measured Using [18F]THK5317 Pet and Cognitive Functions in Alzheimer's Disease Alzheimer's & Dementia. 12: P539-P540. DOI: 10.1016/J.Jalz.2016.06.1056  0.837
2015 Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404. PMID 26553227 DOI: 10.1038/Srep16404  0.839
2015 Kumar R, Nordberg A, Darreh-Shori T. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Brain : a Journal of Neurology. PMID 26525916 DOI: 10.1093/Brain/Awv318  0.372
2015 Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/Wnl.0000000000002081  0.695
2015 Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment. Journal of Alzheimer's Disease : Jad. 47: 691-704. PMID 26401704 DOI: 10.3233/Jad-132474  0.661
2015 Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, Blennow K, Portelius E, Zetterberg H, Nordberg A. Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition. Journal of Alzheimer's Disease : Jad. 47: 661-7. PMID 26401701 DOI: 10.3233/Jad-141965  0.779
2015 Kuang G, Murugan NA, Tu Y, Nordberg A, Ågren H. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods. The Journal of Physical Chemistry. B. 119: 11560-7. PMID 26266837 DOI: 10.1021/Acs.Jpcb.5B05964  0.349
2015 Lilja AM, Malmsten L, Röjdner J, Voytenko L, Verkhratsky A, Ögren SO, Nordberg A, Marutle A. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs. Neural Plasticity. 2015: 370432. PMID 26257960 DOI: 10.1155/2015/370432  0.35
2015 Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue. Acta Neuropathologica Communications. 3: 40. PMID 26134112 DOI: 10.1186/S40478-015-0220-4  0.758
2015 Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-506. PMID 26130168 DOI: 10.1007/S00259-015-3115-5  0.813
2015 Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, ... ... Nordberg A, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669  0.634
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Nordberg A, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668  0.522
2015 Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1119-32. PMID 25893384 DOI: 10.1007/S00259-015-3047-0  0.701
2015 Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, et al. First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study. Plos One. 10: e0098153. PMID 25789616 DOI: 10.1371/journal.pone.0098153  0.314
2015 Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, ... Nordberg A, et al. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25676388 DOI: 10.1016/J.Jalz.2014.11.008  0.394
2015 Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 1077-88. PMID 25649653 DOI: 10.3233/Jad-142952  0.854
2015 Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25646957 DOI: 10.1016/J.Jalz.2014.12.001  0.807
2015 Nordberg A. Dementia in 2014. Towards early diagnosis in Alzheimer disease. Nature Reviews. Neurology. 11: 69-70. PMID 25623789 DOI: 10.1038/Nrneurol.2014.257  0.462
2015 Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology. 84: 508-15. PMID 25568301 DOI: 10.1212/Wnl.0000000000001209  0.74
2015 Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, ... ... Nordberg A, et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. European Journal of Nuclear Medicine and Molecular Imaging. 42: 438-46. PMID 25412766 DOI: 10.1007/S00259-014-2955-8  0.48
2015 Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, ... ... Nordberg A, et al. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 195-206.e1. PMID 25150733 DOI: 10.1016/J.Jalz.2014.06.006  0.516
2015 Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Blennow K, Langstrom B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment Journal of Alzheimer's Disease. 47: 691-704. DOI: 10.3233/JAD-132474  0.542
2015 Ni R, Gillberg P, Viitanen M, Myllykangas L, Bogdanovic N, Nennesmo I, Långström B, Nordberg A. P4-254: Characterization of regional binding of clinical amyloid tracers in autosomal dominant and sporadic Alzheimer's disease brains and their interactions with resveratrol Alzheimer's & Dementia. 11: P878-P878. DOI: 10.1016/J.Jalz.2015.08.083  0.705
2015 Nordberg A. O4-07-05: 18F-(S).THK5117 as a PET tracer for tau pathology in Alzheimer's disease and non-alzheimer's disease dementia Alzheimer's & Dementia. 11: P285-P285. DOI: 10.1016/J.Jalz.2015.07.385  0.494
2015 Caroli A, Galluzzi S, Ferrari C, Prestia A, Flier WMvd, Ossenkoppele R, Berckel BNMv, Barkhof F, Teunissen CE, Wall A, Carter SF, Scholl M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.064  0.742
2015 Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. IC-P-126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P86-P86. DOI: 10.1016/J.Jalz.2015.06.148  0.829
2015 Varrone A, Nordberg A. Molecular imaging of neuroinflammation in Alzheimer’s disease Clinical and Translational Imaging. 3: 437-447. DOI: 10.1007/S40336-015-0137-8  0.505
2015 Nordberg A. The use of amyloid imaging in clinical praxis: a critical review Clinical and Translational Imaging. 3: 7-11. DOI: 10.1007/S40336-015-0100-8  0.524
2015 Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-1506. DOI: 10.1007/s00259-015-3115-5  0.643
2014 Almkvist O, Kadir A, Nordberg A. Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case. Neurocase. 1-10. PMID 25494540 DOI: 10.1080/13554794.2014.979835  0.647
2014 Murugan NA, Zale?ny R, Kongsted J, Nordberg A, Ågren H. Promising two-photon probes for in vivo detection of β amyloid deposits. Chemical Communications (Cambridge, England). 50: 11694-7. PMID 25141215 DOI: 10.1039/C4Cc03897E  0.375
2014 Verkhratsky A, Marutle A, Rodríguez-Arellano JJ, Nordberg A. Glial Asthenia and Functional Paralysis: A New Perspective on Neurodegeneration and Alzheimer's Disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. PMID 25125026 DOI: 10.1177/1073858414547132  0.412
2014 Choo IL, Carter SF, Schöll ML, Nordberg A. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2120-6. PMID 25077930 DOI: 10.1007/S00259-014-2859-7  0.794
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, ... ... Nordberg A, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.477
2014 Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B. Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275: 204-13. PMID 24605805 DOI: 10.1111/Joim.12199  0.428
2014 Nordberg A. Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk. Neuro-Degenerative Diseases. 13: 160-2. PMID 24434947 DOI: 10.1159/000356333  0.503
2014 Darreh-Shori T, Hosseini SM, Nordberg A. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors. Journal of Alzheimer's Disease : Jad. 39: 423-40. PMID 24217282 DOI: 10.3233/Jad-130845  0.374
2014 Nordberg A. The value of multi-PET tracers imaging for Alzheimer's disease therapy evolution Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.099  0.443
2014 Nordberg A. Astroglia and microglia imaging markers in the progression of Alzheimer's disease Neurobiology of Aging. 35: S17-S18. DOI: 10.1016/J.Neurobiolaging.2014.01.098  0.414
2014 Lemoine L, Gillberg P, Marutle A, Antoni G, Eriksson J, Estrada S, Nennesmo I, Okamura N, Nordberg A. IC-P-212: CHARACTERIZATION OF THK5117 BINDING IN AD BRAIN TISSUE: IMPLICATION FOR DEVELOPMENT OF PET TAU IMAGING Alzheimer's & Dementia. 10: P115-P115. DOI: 10.1016/j.jalz.2014.05.220  0.328
2014 Chiotis K, Carter SF, Farid K, Nordberg A. P3-218: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P710-P711. DOI: 10.1016/j.jalz.2014.05.1309  0.612
2014 Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. P3-215: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P709-P710. DOI: 10.1016/j.jalz.2014.05.1306  0.706
2014 Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Per A, Kadir A, Linderoth B, Andreasen N, Nordberg A, Wall A, Wahlund L, Seiger Å, Wahlberg L, Darreh-Shori T, Eriksdotter M. Ngf Cell Therapy In Ad Patients: Effects On Csf Cholinergic Biomarkers Alzheimers & Dementia. 10: 620. DOI: 10.1016/J.Jalz.2014.05.1067  0.346
2014 Eyjolfsdottir H, Per A, Lind G, Linderoth B, Karami A, Almkvist O, Andreasen N, Blennow K, Jelic V, Nordberg A, Sundström E, Wahlund L, Wall A, Wiberg MK, Winblad B, et al. Encapsulated Cell Biodelivery Of Ngf To Cholinergic Basal Forebrain In Alzheimer'S Disease Patients: A Dose-Escalation Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1063  0.575
2014 Chiotis K, Carter SF, Farid K, Nordberg A. IC-P-025: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P18-P18. DOI: 10.1016/J.Jalz.2014.05.029  0.769
2014 Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. IC-P-019: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P16-P16. DOI: 10.1016/J.Jalz.2014.05.023  0.716
2014 Ni R, Rodriguez-Vieitez E, Voytenko L, Marutle A, Nordberg A. Different Time Course Of Astrocytosis And Amyloid Deposition In Alzheimer'S Appswe Transgenice Mice: A Multi-Tracer Micropet Study Alzheimers & Dementia. 10: 253. DOI: 10.1016/J.Jalz.2014.04.394  0.69
2014 Caroli A, Frisoni G, Prestia A, Galluzzi S, Ferrari C, Flier WMVd, Ossenkoppele R, Berckel Bv, Barkhof F, Teunissen C, Wall A, Carter SF, Schöll M, Choo IH, Grimmer T, ... Nordberg A, et al. Mild Cognitive Impairment With Suspected Non Ad Pathology (Snap): Prediction Of Progression To Dementia Alzheimers & Dementia. 10: 19-19. DOI: 10.1016/J.Jalz.2014.04.230  0.758
2014 Lemoine L, Gillberg P, Marutle A, Antoni G, Eriksson J, Estrada S, Nennesmo I, Okamura N, Nordberg A. O1-12-04: CHARACTERIZATION OF THK5117 BINDING IN AD BRAIN TISSUE: IMPLICATION FOR DEVELOPMENT OF PET TAU IMAGING Alzheimer's & Dementia. 10: P155-P155. DOI: 10.1016/J.Jalz.2014.04.125  0.404
2013 Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. The Primary Care Companion For Cns Disorders. 15. PMID 23930233 DOI: 10.4088/Pcc.12R01412  0.438
2013 Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8  0.57
2013 Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10: 90. PMID 23880036 DOI: 10.1186/1742-2094-10-90  0.724
2013 Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, LÃ¥ngström B, Almkvist O, Nordberg A. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. Neurobiology of Aging. 34: 2465-81. PMID 23759148 DOI: 10.1016/J.Neurobiolaging.2013.04.027  0.576
2013 Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Brain : a Journal of Neurology. 136: 2217-27. PMID 23757761 DOI: 10.1093/Brain/Awt142  0.685
2013 Lilja AM, Röjdner J, Mustafiz T, Thomé CM, Storelli E, Gonzalez D, Unger-Lithner C, Greig NH, Nordberg A, Marutle A. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels. Plos One. 8: e58752. PMID 23554921 DOI: 10.1371/Journal.Pone.0058752  0.378
2013 Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80: 1048-56. PMID 23390179 DOI: 10.1212/Wnl.0B013E3182872830  0.731
2013 Lilja AM, Luo Y, Yu QS, Röjdner J, Li Y, Marini AM, Marutle A, Nordberg A, Greig NH. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease. Plos One. 8: e54887. PMID 23382994 DOI: 10.1371/Journal.Pone.0054887  0.359
2013 Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/J.Neuroimage.2012.12.014  0.718
2013 Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/Jad-2012-121489  0.793
2013 Ni R, Marutle A, Nordberg A. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 33: 841-51. PMID 23042213 DOI: 10.3233/Jad-2012-121447  0.706
2013 Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, LÃ¥ngström B, Scheinin N, Karrasch M, NÃ¥gren K, Grimmer T, Miederer I, Edison P, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2  0.802
2013 Chiotis K, Carter S, Nordberg A. P1-320: Comparison of PiB-PET data to florbetapir-PET data acquired from cohorts at different research sites Alzheimer's & Dementia. 9: P275-P275. DOI: 10.1016/J.Jalz.2013.05.546  0.757
2013 Chiotis K, Carter S, Nordberg A. Comparison of PiB-PET data to florbetapir-PET data acquired from different patient cohorts at different research sites Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.007  0.773
2013 Schöll M, Carter S, Westman E, Almkvist O, Wall A, Graff C, Långström B, Nordberg A. O4-07-02: Longitudinal multi-tracer positron emission tomography studies of astrocytosis, fibrillar amlyloid deposition and cerebral glucose metabolism during development of early-onset familial Alzheimer's disease Alzheimer's & Dementia. 9: P695-P695. DOI: 10.1016/J.Jalz.2013.04.372  0.797
2013 Rodriguez-Vieitez E, Ni R, Gulyás B, Toth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid deposition in Alzheimer’s disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study Alzheimers & Dementia. 9: 337. DOI: 10.1016/J.Jalz.2013.04.197  0.66
2012 Sugaya K, Youdim MB, Nordberg A, Rao KS. Neuroprotection and neuroregeneration in Alzheimer's disease. International Journal of Alzheimer's Disease. 2012: 864138. PMID 22737586 DOI: 10.1155/2012/864138  0.424
2012 Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, LÃ¥ngström B, Almkvist O, Graff C, Nordberg A. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 79: 229-36. PMID 22700814 DOI: 10.1212/Wnl.0B013E31825Fdf18  0.628
2012 Eriksdotter-Jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, et al. Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 33: 18-28. PMID 22377499 DOI: 10.1159/000336051  0.609
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, ... ... Nordberg A, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0  0.572
2012 Carter SF, Schöll M, Almkvist O, Wall A, Engler H, LÃ¥ngström B, Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 37-46. PMID 22213821 DOI: 10.2967/Jnumed.110.087031  0.787
2012 Forsberg A, Engler H, Blomquist G, LÃ¥ngström B, Nordberg A. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochimica Et Biophysica Acta. 1822: 380-5. PMID 22115832 DOI: 10.1016/J.Bbadis.2011.11.006  0.522
2012 Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 443-58. PMID 22012848 DOI: 10.3233/Jad-2011-111088  0.306
2012 Bao F, Wicklund L, Lacor PN, Klein WL, Nordberg A, Marutle A. Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiology of Aging. 33: 825.e1-13. PMID 21683475 DOI: 10.1016/J.Neurobiolaging.2011.05.003  0.462
2012 Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, LÃ¥ngström B, Nordberg A. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of Aging. 33: 198.e1-14. PMID 20688420 DOI: 10.1016/J.Neurobiolaging.2010.06.015  0.687
2012 Nordberg A. 59 A decade of amyloid PET imaging: advances in neuroinflammation Neurobiology of Aging. 33: S26. DOI: 10.1016/J.Neurobiolaging.2012.01.077  0.431
2012 Wicklund L, Lilja A, Nordberg A, Marutle A. 48 Revamping the cholinergic system in Alzheimer's disease: Experience from stem cell studies Neurobiology of Aging. 33: S21. DOI: 10.1016/J.Neurobiolaging.2012.01.066  0.355
2011 Nordberg A. Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development. Alzheimer's Research & Therapy. 3: 34. PMID 22136152 DOI: 10.1186/Alzrt96  0.531
2011 Lithner CU, Hedberg MM, Nordberg A. Transgenic mice as a model for Alzheimer's disease. Current Alzheimer Research. 8: 818-31. PMID 21592052 DOI: 10.2174/156720511798192736  0.426
2011 Mustafiz T, Portelius E, Gustavsson MK, Hölttä M, Zetterberg H, Blennow K, Nordberg A, Lithner CU. Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. Neuro-Degenerative Diseases. 8: 352-63. PMID 21346320 DOI: 10.1159/000323871  0.459
2011 Shafaati M, Marutle A, Pettersson H, Lövgren-Sandblom A, Olin M, Pikuleva I, Winblad B, Nordberg A, Björkhem I. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. Journal of Lipid Research. 52: 1004-10. PMID 21335619 DOI: 10.1194/Jlr.M014548  0.413
2011 Schöll M, Almkvist O, Bogdanovic N, Wall A, LÃ¥ngström B, Viitanen M, Nordberg A. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. Journal of Alzheimer's Disease : Jad. 24: 495-506. PMID 21297272 DOI: 10.3233/Jad-2011-101563  0.61
2011 Keller C, Kadir A, Forsberg A, Porras O, Nordberg A. Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 24: 109-23. PMID 21157026 DOI: 10.3233/Jad-2010-101290  0.443
2011 Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain : a Journal of Neurology. 134: 301-17. PMID 21149866 DOI: 10.1093/Brain/Awq349  0.656
2011 Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/J.Pneurobio.2010.11.005  0.413
2011 Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 23: 335-47. PMID 21116052 DOI: 10.3233/Jad-2010-101242  0.427
2011 Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, LÃ¥ngström B, Nordberg A. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiology of Aging. 32: 2320.e15-32. PMID 20538374 DOI: 10.1016/J.Neurobiolaging.2010.04.028  0.665
2011 Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, LÃ¥ngström B, Lannfelt L, Graff C, Nordberg A. Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiology of Aging. 32: 1388-99. PMID 19796846 DOI: 10.1016/J.Neurobiolaging.2009.08.016  0.64
2011 Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiology of Aging. 32: 1236-48. PMID 19713000 DOI: 10.1016/J.Neurobiolaging.2009.07.015  0.424
2011 Ng Y, Nordberg A, Carter S, Schöll M, Kadir A. P4-358: Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort Alzheimer's & Dementia. 7: e37-e38. DOI: 10.1016/J.Jalz.2011.09.173  0.75
2011 Thomé C, Ni R, Gillberg P, Marutle A, Nordberg A. P4-301: Evolution of fibrillar amyloid in relation to astro- and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi-tracer concept Alzheimer's & Dementia. 7: e16-e17. DOI: 10.1016/J.Jalz.2011.09.046  0.663
2011 Schöll M, Almkvist O, Graff C, Nordberg A. O2-06-08: Amyloid imaging in members of a family harbouring the Arctic APP mutation Alzheimer's & Dementia. 7: S303-S303. DOI: 10.1016/J.Jalz.2011.05.880  0.667
2011 Carter SF, Nordberg A, Schöll M, Almkvist O, Wall A, Engler H, Långström B. O1-07-05: Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG Alzheimer's & Dementia. 7: S110-S110. DOI: 10.1016/J.Jalz.2011.05.276  0.811
2011 Lithner CU, Hernandez C, Sweatt JD, Nordberg A. O3-05-05: Epigenetic effects of Aβ and the implication on the pathophysiology in Alzheimer's disease Alzheimer's & Dementia. 7: S508-S508. DOI: 10.1016/J.Jalz.2011.05.1420  0.4
2011 Ni R, Marutle A, Nordberg A. P2-487: Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain Alzheimer's & Dementia. 7: S468-S468. DOI: 10.1016/J.Jalz.2011.05.1358  0.655
2011 Wicklund L, Marutle A, Hertwig L, Hovatta O, Nordberg A, Darreh-Shori T. The influence of beta-amyloid 1-42 on inflammatory processes and regenerative mechanisms in Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1209  0.376
2011 Marutle A, Bergfors A, Ni R, Nennesmo I, Gillberg P, Nordberg A. P2-329: Laminar distributions of fibrillar β-amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study Alzheimer's & Dementia. 7: S414-S415. DOI: 10.1016/J.Jalz.2011.05.1205  0.693
2011 Darreh-Shori T, Bälter M, Siawesh M, Nordberg A. Impact of Butyrylcholinesterase K genotype on glial and proinflammatory markers in CSF of patients with Alzheimer's disease. Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1181  0.37
2011 Bao F, Lacor P, Klein W, Marutle A, Nordberg A. P2-213: Different distribution of soluble beta-amyloid assemblies in the Tg2576 mouse brain and Alzheimer disease autopsy brain Alzheimer's & Dementia. 7: S380-S381. DOI: 10.1016/J.Jalz.2011.05.1096  0.387
2010 Wicklund L, Leão RN, Strömberg AM, Mousavi M, Hovatta O, Nordberg A, Marutle A. Î’-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. Plos One. 5: e15600. PMID 21179413 DOI: 10.1371/Journal.Pone.0015600  0.39
2010 Kadir A, Nordberg A. Target-specific PET probes for neurodegenerative disorders related to dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1418-30. PMID 20810758 DOI: 10.2967/Jnumed.110.077164  0.475
2010 Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neuro-Degenerative Diseases. 7: 379-88. PMID 20689242 DOI: 10.1159/000287954  0.44
2010 Degerman Gunnarsson M, Lindau M, Wall A, Blennow K, Darreh-Shori T, Basu S, Nordberg A, Larsson A, Lannfelt L, Basun H, Kilander L. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dementia and Geriatric Cognitive Disorders. 29: 204-12. PMID 20332638 DOI: 10.1159/000281832  0.494
2010 Forsberg A, Almkvist O, Engler H, Wall A, LÃ¥ngström B, Nordberg A. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Current Alzheimer Research. 7: 56-66. PMID 20205671 DOI: 10.2174/156720510790274446  0.67
2010 Nordberg A. Amyloid imaging in early detection of Alzheimer's disease. Neuro-Degenerative Diseases. 7: 136-8. PMID 20197692 DOI: 10.1159/000289223  0.527
2010 Nordberg A, Rinne JO, Kadir A, LÃ¥ngström B. The use of PET in Alzheimer disease. Nature Reviews. Neurology. 6: 78-87. PMID 20139997 DOI: 10.1038/Nrneurol.2009.217  0.537
2010 Lilja A, Porras O, Storelli E, Nordberg A, Marutle A. P.1.022 Amyloid aggregation is critical for the interaction with neuronal nicotinic acetylcholine receptors (nAChRs) – implications for neuroprotection in Alzheimer's disease European Neuropsychopharmacology. 20: S19-S20. DOI: 10.1016/S0924-977X(10)70024-9  0.391
2010 Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. P4-089: Investigating Astrocytes With C11-deuterium Deprenyl in Mild Cognitive Impairment and Mild Alzheimer's - A Multi-tracer Positron Emission Tomography Paradigm Alzheimer's & Dementia. 6: e48-e49. DOI: 10.1016/J.Jalz.2010.08.149  0.803
2010 Schöll M, Almkvist O, Wall A, Engler H, Kinhult-Ståhlbom A, Graff C, Nordberg A. Multitracer PET studies in kindreds with early-onset familial Alzheimer gene mutations Alzheimer's & Dementia. 6: S294. DOI: 10.1016/J.Jalz.2010.05.965  0.709
2009 Ferris S, Nordberg A, Soininen H, Darreh-Shori T, Lane R. Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment. Pharmacogenetics and Genomics. 19: 635-46. PMID 19617863 DOI: 10.1097/Fpc.0B013E32832F8C17  0.418
2009 Nordberg A. Molecular imaging markers in clinical trials in Alzheimer s disease. The Journal of Nutrition, Health & Aging. 13: 346-7. PMID 19300875 DOI: 10.1007/S12603-009-0038-5  0.378
2009 Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Current Alzheimer Research. 6: 4-14. PMID 19199870 DOI: 10.2174/156720509787313961  0.415
2009 Nordberg A. The future: new methods of imaging exploration in Alzheimer's disease. Frontiers of Neurology and Neuroscience. 24: 47-53. PMID 19182462 DOI: 10.1159/000197883  0.508
2009 Svedberg MM, Hall H, Hellström-Lindahl E, Estrada S, Guan Z, Nordberg A, LÃ¥ngström B. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochemistry International. 54: 347-57. PMID 19162107 DOI: 10.1016/J.Neuint.2008.12.016  0.436
2009 Nordberg A, Forsberg A, Kadir A, Almkvist O, Engler H, Långström B. S.4.02 Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimer's disease European Neuropsychopharmacology. 19: S125-S126. DOI: 10.1016/S0924-977X(09)70133-6  0.627
2009 Kadir A, Zetterberg H, Andreasen N, Almkvist O, Wall A, Forsberg A, Blennow K, Långström B, Nordberg A. IC-O2-03: Long-term effect of phenserine treatment in Alzheimer patients as assessed by PET and CSF biomarkers Alzheimer's & Dementia. 5: P6-P6. DOI: 10.1016/J.Jalz.2009.05.019  0.58
2009 Nordberg A, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Almkvist O, Scheinin N, Grimmer T, Okello A, Van Laere K, Hinz R, Carter SF, Kalbe E, Herholz K. IC-S1-03: PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Alzheimer's & Dementia. 5: P2-P2. DOI: 10.1016/J.Jalz.2009.05.006  0.759
2009 Darreh-Shori T, Modiri N, Nordberg A. ApoE and amyloid beta deflate the cholinergic neurotransmission by boosting the activity and stability of cholinesterases in the brain Alzheimers & Dementia. 5: 305. DOI: 10.1016/J.Jalz.2009.04.463  0.329
2009 Lithner CU, Hernandez CM, Nordberg A, Sweatt JD. P2-146: Epigenetic changes related to beta-amyloid-implications for Alzheimer's disease Alzheimer's & Dementia. 5: P304-P304. DOI: 10.1016/J.Jalz.2009.04.457  0.389
2008 Blomquist G, Engler H, Nordberg A, Ringheim A, Wall A, Forsberg A, Estrada S, Frändberg P, Antoni G, Långström B. Unidirectional Influx and Net Accumulation of PIB. The Open Neuroimaging Journal. 2: 114-25. PMID 19526073 DOI: 10.2174/1874440000802010114  0.419
2008 Nordberg A. Amyloid imaging in Alzheimer's disease. Neuropsychologia. 46: 1636-41. PMID 18468648 DOI: 10.1016/J.Neuropsychologia.2008.03.020  0.492
2008 Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18: 289-98. PMID 18334913 DOI: 10.1097/Fpc.0B013E3282F63F29  0.392
2008 Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, LÃ¥ngström B, Nordberg A. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. 63: 621-31. PMID 18300284 DOI: 10.1002/Ana.21345  0.656
2008 Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. European Journal of Nuclear Medicine and Molecular Imaging. 35: S46-50. PMID 18188557 DOI: 10.1007/S00259-007-0700-2  0.477
2008 Hedberg MM, Svedberg MM, Mustafiz T, Yu WF, Mousavi M, Guan ZZ, Unger C, Nordberg A. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Neuroscience. 152: 223-33. PMID 18164554 DOI: 10.1016/J.Neuroscience.2007.11.022  0.327
2008 Johansson A, Savitcheva I, Forsberg A, Engler H, LÃ¥ngström B, Nordberg A, Askmark H. [(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results. Parkinsonism & Related Disorders. 14: 345-7. PMID 17855149 DOI: 10.1016/J.Parkreldis.2007.07.010  0.416
2008 Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, LÃ¥ngström B, Kilander L. In vivo amyloid imaging with PET in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 35: 100-6. PMID 17846768 DOI: 10.1007/S00259-007-0523-1  0.54
2008 Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, LÃ¥ngström B, Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging. 29: 1456-65. PMID 17499392 DOI: 10.1016/J.Neurobiolaging.2007.03.029  0.682
2008 Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, Ringheim A, B Eriksson, Blomquist G, LÃ¥ngström B, Nordberg A. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiology of Aging. 29: 1204-17. PMID 17379359 DOI: 10.1016/J.Neurobiolaging.2007.02.020  0.612
2008 Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, LÃ¥ngström B, Nordberg A. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. Neurobiology of Aging. 29: 168-84. PMID 17196712 DOI: 10.1016/J.Neurobiolaging.2006.09.020  0.608
2008 Hellström-Lindahl E, Ravid R, Nordberg A. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiology of Aging. 29: 210-21. PMID 17098332 DOI: 10.1016/J.Neurobiolaging.2006.10.010  0.356
2008 Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. IC-P2-134: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T60-T60. DOI: 10.1016/J.Jalz.2008.05.2589  0.741
2008 Darreh-Shori T, Forsberg A, Andreasen N, Blennow K, Wall A, Kamil C, Långström B, Nordberg A. P3-293: Interaction between amyloid-beta peptides with butyrylcholinesterase and ApoE proteins: Mechanism of amyloid fibrils deposition in the brain of patients with Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1861  0.41
2008 Almkvist O, Forsberg A, Nordberg A. P3-105: Low episodic memory performance is related to high PET PIB levels in asymptomatic control subjects Alzheimer's & Dementia. 4: T549-T549. DOI: 10.1016/J.Jalz.2008.05.1670  0.542
2008 Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. P2-075: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T390-T390. DOI: 10.1016/J.Jalz.2008.05.1148  0.751
2008 Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-026: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T375-T375. DOI: 10.1016/J.Jalz.2008.05.1106  0.621
2008 Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. IC-P2-107: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T50-T50. DOI: 10.1016/J.Jalz.2008.05.100  0.605
2007 Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proceedings of the National Academy of Sciences of the United States of America. 104: 12506-11. PMID 17640880 DOI: 10.1073/Pnas.0705346104  0.346
2007 Nordberg A. Amyloid imaging in Alzheimer's disease. Current Opinion in Neurology. 20: 398-402. PMID 17620873 DOI: 10.1097/Wco.0B013E3281A47744  0.468
2007 Famer D, Meaney S, Mousavi M, Nordberg A, Björkhem I, Crisby M. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochemical and Biophysical Research Communications. 359: 46-50. PMID 17532301 DOI: 10.1016/J.Bbrc.2007.05.033  0.321
2007 Roensch J, Crisby M, Nordberg A, Xiao Y, Zhang LJ, Guan ZZ. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochemistry International. 50: 800-6. PMID 17412455 DOI: 10.1016/J.Neuint.2007.02.001  0.356
2007 Celsi F, Svedberg M, Unger C, Cotman CW, Carrì MT, Ottersen OP, Nordberg A, Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiology of Disease. 26: 342-52. PMID 17344052 DOI: 10.1016/J.Nbd.2006.12.022  0.385
2007 Kadir A, Darreh-Shori T, Almkvist O, Wall A, LÃ¥ngström B, Nordberg A. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology. 191: 1005-14. PMID 17310387 DOI: 10.1007/S00213-007-0725-Z  0.67
2007 Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM, Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, ... ... Nordberg A, et al. Disease mechanisms in neuroscience Neuroscientist. 13: 99. DOI: 10.1177/10738584070130020301  0.535
2007 Unger C, Hernandez C, Nordberg A, Sweatt J. P.1.01 Modification of histone H3 and H4 in the brain of Tg2576 transgenic mice – implications for Alzheimer's disease European Neuropsychopharmacology. 17: S2-S3. DOI: 10.1016/S0924-977X(07)00046-6  0.335
2007 Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Langstrom B, Nordberg A. PET imaging of amyloid depositions in MCI patients using PIB Journal of Cerebral Blood Flow and Metabolism. 27: BO03-01.  0.335
2006 Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiology of Disease. 24: 326-33. PMID 16973370 DOI: 10.1016/J.Nbd.2006.07.013  0.638
2006 Darreh-Shori T, Meurling L, Pettersson T, Hugosson K, Hellström-Lindahl E, Andreasen N, Minthon L, Nordberg A. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 1791-801. PMID 16868793 DOI: 10.1007/S00702-006-0526-2  0.398
2006 Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, LÃ¥ngström B, Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain : a Journal of Neurology. 129: 2856-66. PMID 16854944 DOI: 10.1093/Brain/Awl178  0.698
2006 Kadir A, Almkvist O, Wall A, LÃ¥ngström B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology. 188: 509-20. PMID 16832659 DOI: 10.1016/J.Neuroimage.2006.04.135  0.65
2006 Nordberg A. Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease. Alzheimer Disease and Associated Disorders. 20: S12-8. PMID 16772751 DOI: 10.1097/01.Wad.0000213804.59187.2D  0.418
2006 Kelicen P, Nordberg A. Feedback regulation of SREBP and aromatase in A beta(25-35)-supplemented human neuroblastoma cells. Cellular and Molecular Neurobiology. 26: 225-35. PMID 16767510 DOI: 10.1007/S10571-006-9060-X  0.351
2006 Mousavi M, Nordberg A. Expression of the alpha7, alpha4 and alpha3 nicotinic receptor subtype in the brain and adrenal medulla of transgenic mice carrying genes coding for human AChE and beta-amyloid. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 24: 269-73. PMID 16574369 DOI: 10.1016/J.Ijdevneu.2006.02.002  0.328
2006 Unger C, Svedberg MM, Yu WF, Hedberg MM, Nordberg A. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. 317: 30-6. PMID 16354790 DOI: 10.1124/Jpet.105.098566  0.361
2006 Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, LÃ¥ngström B, Nordberg A. Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 205-18. PMID 16049637 DOI: 10.1007/S00702-005-0312-6  0.645
2006 Nordberg A. Emerging biology of the cholinergic system across the spectrum of Alzheimer's disease International Psychogeriatrics. 18: S3-S16. DOI: 10.1017/S1041610206003991  0.507
2006 HERHOLZ K, NORDBERG A, MASDEU J, GERHARD A, EBMEIER K, PAPPATA S, PERANI D, VANLAERE K, HALLDIN C, SALMON E. Imaging of Neurotransmitter Deficits: New Potential Biomarkers for Alzheimer’s Disease? Neurorx. 3: 412-412. DOI: 10.1016/J.Nurx.2006.05.026  0.495
2006 Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. P2-136: Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ϵ4 allele, in relation to cognitive function and cerebral glucose metabolism Alzheimer's & Dementia. 2: S273-S273. DOI: 10.1016/J.Jalz.2006.05.974  0.612
2006 Hedberg MM, Svedberg MM, Mustafiz T, Unger C, Nordberg A. P1-058: Different effects of L-(-)-nicotine on beta-amyloid pathology in the brain of two transgenic mouse models Alzheimer's & Dementia. 2: S111-S112. DOI: 10.1016/J.Jalz.2006.05.433  0.332
2006 Mousavi M, Svedberg M, Unger C, Yu W, Guan Z, Nordberg A. P1-047: Consequences of increased β-amyloid levels at different ages in the brain of transgenic mice overexpressing both human acetylcholinesterase and the APPswe mutation Alzheimer's & Dementia. 2: S108-S108. DOI: 10.1016/J.Jalz.2006.05.422  0.316
2006 Kadir A, Schöll M, Forsberg A, Wall A, Långström B, Nordberg A. IC-P-010: Age and ApoE interaction in Alzheimer’s disease: FDG PET study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.2215  0.633
2006 Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-304: PET imaging of cortical 11 C-nicotine binding correlates with cognitive function of attention in Alzheimer's disease Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1144  0.641
2006 Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. P2-303: Amyloid depositions in MCI-patients studied with PIB-PET Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1143  0.634
2006 Scholl M, Kadir A, Forsberg A, Wall A, Langstrom B, Nordberg A. P2-267: Regional cerebral glucose metabolism (CMRGLC) as measured BY 18FDG-PET and Abeta1-42 and tau levels in CSF of Alzheimer patients who are carriers or non-carriers of the APOE ε4 allele genotype Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1106  0.668
2005 Unger C, Hedberg MM, Mustafiz T, Svedberg MM, Nordberg A. Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels. Molecular and Cellular Neurosciences. 30: 218-27. PMID 16107318 DOI: 10.1016/J.Mcn.2005.07.012  0.326
2005 Xiu J, Nordberg A, Zhang JT, Guan ZZ. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochemistry International. 47: 281-90. PMID 15955596 DOI: 10.1016/J.Neuint.2005.04.023  0.307
2005 Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Experimental Neurology. 192: 215-25. PMID 15698636 DOI: 10.1016/J.Expneurol.2004.12.015  0.379
2005 Francis PT, Nordberg A, Arnold SE. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends in Pharmacological Sciences. 26: 104-11. PMID 15681028 DOI: 10.1016/J.Tips.2004.12.010  0.434
2005 Blomquist G, Hinz R, Engler H, Nordberg A, Långström B. Different patterns of PIB uptake in AD patients Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0666  0.38
2005 Forsberg A, Engler H, Larsson E, Blomquist G, Wall A, Långström B, Nordberg A. Follow-up study of amyloid deposition and glucose metabolism in patients with Alzheimer's disease Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0415  0.426
2004 Nordberg A. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? European Journal of Nuclear Medicine and Molecular Imaging. 31: 1540-3. PMID 15372212 DOI: 10.1007/s00259-004-1677-8  0.358
2004 Nordberg A. PET imaging of amyloid in Alzheimer's disease. The Lancet. Neurology. 3: 519-27. PMID 15324720 DOI: 10.1016/S1474-4422(04)00853-1  0.519
2004 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/J.1365-2796.2004.01380.X  0.537
2004 Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 253-61. PMID 15061827 DOI: 10.1046/J.1468-1331.2003.00757.X  0.615
2004 Darreh-Shori T, Hellström-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. Journal of Neurochemistry. 88: 1102-13. PMID 15009666 DOI: 10.1046/J.1471-4159.2003.02230.X  0.399
2004 Hellström-Lindahl E, Mousavi M, Ravid R, Nordberg A. Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiology of Disease. 15: 351-60. PMID 15006705 DOI: 10.1016/J.Nbd.2003.11.024  0.404
2004 Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology. 55: 306-19. PMID 14991808 DOI: 10.1002/Ana.20009  0.469
2004 Nordberg A. Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. Progress in Brain Research. 145: 301-10. PMID 14650924 DOI: 10.1016/S0079-6123(03)45021-8  0.49
2004 Yu W, Guan Z, Bogadanovic N, Nordberg A. P3-163 Higher expression of alpha7 nicotinic receptor on astrocytes in Alzheimer patients with Swedish APP 670/671mutation compared to sporadic Alzheimer's disease Neurobiology of Aging. 25: S402. DOI: 10.1016/S0197-4580(04)81315-0  0.406
2004 Stefanova E, Axelman K, Almkvist O, Wall A, Lannfelt L, Lngström B, Nordberg A. P3-083 FDG PET reveals decreased cerebral glucose metabolism in presymptomatic carriers of the HIS163TYR mutation in the presenilin-1 gene at risk for developing familial Alzheimer's disease Neurobiology of Aging. 25: S377. DOI: 10.1016/S0197-4580(04)81235-1  0.615
2004 Nordberg A, Engler H, Blomqvist G, Almkvist O, Ausén B, Wall A, Lngström B. O3-03-08 Imaging of amyloid in brain in vivo in MCI and AD patients Neurobiology of Aging. 25: S59. DOI: 10.1016/S0197-4580(04)80198-2  0.611
2003 Klunk WE, Engler H, Nordberg A, Bacskai BJ, Wang Y, Price JC, Bergström M, Hyman BT, LÃ¥ngström B, Mathis CA. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Neuroimaging Clinics of North America. 13: 781-9, ix. PMID 15024961 DOI: 10.1016/S1052-5149(03)00092-3  0.499
2003 Nordberg A. Toward an early diagnosis and treatment of Alzheimer's disease. International Psychogeriatrics / Ipa. 15: 223-37. PMID 14756159 DOI: 10.1017/S1041610203009499  0.483
2003 Mousavi M, Hellström-Lindahl E, Guan ZZ, Shan KR, Ravid R, Nordberg A. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease. Neuroscience. 122: 515-20. PMID 14614915 DOI: 10.1016/S0306-4522(03)00460-3  0.314
2003 Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurologica Scandinavica. Supplementum. 179: 52-76. PMID 12603252 DOI: 10.1034/J.1600-0404.107.S179.10.X  0.404
2003 Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A. Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients. Neuroscience Letters. 338: 159-63. PMID 12566177 DOI: 10.1016/S0304-3940(02)01384-8  0.642
2003 Yu WF, Nordberg A, Ravid R, Guan ZZ. Correlation of oxidative stress and the loss of the nicotinic receptor alpha 4 subunit in the temporal cortex of patients with Alzheimer's disease. Neuroscience Letters. 338: 13-6. PMID 12565129 DOI: 10.1016/S0304-3940(02)01361-7  0.397
2002 Long YG, Wang YN, Chen J, Jiang SF, Nordberg A, Guan ZZ. Chronic fluoride toxicity decreases the number of nicotinic acetylcholine receptors in rat brain. Neurotoxicology and Teratology. 24: 751-7. PMID 12460657 DOI: 10.1016/S0892-0362(02)00273-8  0.304
2002 Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology. 59: 563-72. PMID 12196650 DOI: 10.1212/Wnl.59.4.563  0.561
2002 Marutle A, Unger C, Hellström-Lindahl E, Wang J, Puoliväli J, Tanila H, Nordberg A, Zhang X. Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neuroscience Letters. 328: 269-72. PMID 12147323 DOI: 10.1016/S0304-3940(02)00546-3  0.329
2002 Bednar I, Paterson D, Marutle A, Pham TM, Svedberg M, Hellström-Lindahl E, Mousavi M, Court J, Morris C, Perry E, Mohammed A, Zhang X, Nordberg A. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Molecular and Cellular Neurosciences. 20: 354-65. PMID 12093166 DOI: 10.1006/Mcne.2002.1112  0.33
2002 Nordberg A, Hellström-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). Journal of Neurochemistry. 81: 655-8. PMID 12065674 DOI: 10.1046/J.1471-4159.2002.00874.X  0.409
2002 Hartvig P, Nordberg A, Torstenson R, Sjöberg P, Fasth KJ, LÃ¥ngström B. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography. Dementia and Geriatric Cognitive Disorders. 13: 199-204. PMID 12006729 DOI: 10.1159/000057697  0.306
2001 Guan ZZ, Miao H, Tian JY, Unger C, Nordberg A, Zhang X. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 1417-33. PMID 11810405 DOI: 10.1007/S007020100017  0.418
2001 Arnáiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12: 851-5. PMID 11277595 DOI: 10.1097/00001756-200103260-00045  0.619
2001 Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biological Psychiatry. 49: 200-10. PMID 11230871 DOI: 10.1016/S0006-3223(00)01125-2  0.428
2001 Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dementia and Geriatric Cognitive Disorders. 12: 22-32. PMID 11125238 DOI: 10.1159/000051232  0.574
2000 Nordberg A. Neuroprotection in Alzheimer's disease - new strategies for treatment. Neurotoxicity Research. 2: 157-65. PMID 16787838 DOI: 10.1007/Bf03033791  0.389
2000 Sihver W, LÃ¥ngström B, Nordberg A. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurologica Scandinavica. Supplementum. 176: 27-33. PMID 11261802 DOI: 10.1034/J.1600-0404.2000.00304.X  0.42
2000 Algotsson A, Nordberg A, Winblad B. Apolipoprotein E varepsilon4 allele has an impact on vascular reactivity in Alzheimer's disease. Archives of Gerontology and Geriatrics. 31: 221-231. PMID 11154777 DOI: 10.1016/S0167-4943(00)00082-0  0.365
2000 Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, Maurer K, Winblad B, Nordberg A. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1817-24. PMID 11018498 DOI: 10.1016/S1388-2457(00)00427-2  0.397
2000 Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED. Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behavioural Brain Research. 113: 143-57. PMID 10942041 DOI: 10.1016/S0166-4328(00)00209-6  0.343
2000 Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiology of Aging. 21: 533-40. PMID 10924766 DOI: 10.1016/S0197-4580(00)00153-6  0.594
2000 Jelic V, Nordberg A. Early diagnosis of Alzheimer disease with positron emission tomography. Alzheimer Disease and Associated Disorders. 14: S109-13. PMID 10850738 DOI: 10.1097/00002093-200000001-00016  0.461
2000 Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Progress in Neurobiology. 61: 75-111. PMID 10759066 DOI: 10.1016/S0301-0082(99)00045-3  0.337
2000 Hellström-Lindahl E, Moore H, Nordberg A. Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists. Journal of Neurochemistry. 74: 777-84. PMID 10646530 DOI: 10.1046/J.1471-4159.2000.740777.X  0.349
2000 Guan ZZ, Zhang X, Ravid R, Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. Journal of Neurochemistry. 74: 237-43. PMID 10617125 DOI: 10.1046/J.1471-4159.2000.0740237.X  0.343
2000 Darreh-Shori T, Svensson A, Nordberg A. Long term rivastigmine treatment produces persistent inhibition of acetyl- and butyrylcholinesterase activity in CSF of Alzheimer's patients Neurobiology of Aging. 21: 243. DOI: 10.1016/S0197-4580(00)83431-4  0.332
2000 Nordberg A. Brain functional imaging in early and preclinical Alzheimer's disease Neurobiology of Aging. 21: 74. DOI: 10.1016/S0197-4580(00)82554-3  0.418
2000 Guan Z, Zhang X, Nordberg A. A possible mechanism for nicotinic acetylcholine receptor deficit in Alzheimer brain—lipid peroxidation and distructure of biological cellular mambrane Neurobiology of Aging. 21: 188. DOI: 10.1016/S0197-4580(00)82187-9  0.322
1999 Nordberg A. PET studies and cholinergic therapy in Alzheimer's disease. Revue Neurologique. 155: S53-63. PMID 10637939  0.354
1999 Sihver W, Fasth KJ, Ogren M, Lundqvist H, Bergström M, Watanabe Y, Långström B, Nordberg A. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys. Nuclear Medicine and Biology. 26: 633-40. PMID 10587101 DOI: 10.1016/S0969-8051(99)00034-7  0.33
1999 Sihver W, Gillberg PG, Svensson AL, Nordberg A. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience. 94: 685-96. PMID 10579560 DOI: 10.1016/S0306-4522(99)00295-X  0.308
1999 Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dementia and Geriatric Cognitive Disorders. 10: 526-33. PMID 10559570 DOI: 10.1159/000017200  0.643
1999 Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 10: 494-504. PMID 10559566 DOI: 10.1159/000017196  0.638
1999 Sihver W, Fasth KJ, Horti AG, Koren AO, Bergström M, Lu L, Hagberg G, Lundqvist H, Dannals RF, London ED, Nordberg A, Långström B. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain. Journal of Neurochemistry. 73: 1264-72. PMID 10461920 DOI: 10.1046/J.1471-4159.1999.0731264.X  0.325
1999 Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 52: 1861-70. PMID 10371535 DOI: 10.1212/Wnl.52.9.1861  0.593
1999 Hellström-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Research. Molecular Brain Research. 66: 94-103. PMID 10095081 DOI: 10.1016/S0169-328X(99)00030-3  0.364
1999 Marutle A, Warpman U, Bogdanovic N, Lannfelt L, Nordberg A. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. Journal of Neurochemistry. 72: 1161-9. PMID 10037489 DOI: 10.1046/J.1471-4159.2000.0721161.X  0.384
1999 Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Nordberg A, et al. Contents Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 553-555. DOI: 10.1159/000017205  0.444
1999 Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Nordberg A, et al. Subject Index Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 551-552. DOI: 10.1159/000017204  0.459
1998 Bednar I, Zhang X, Dastranj-Sedghi R, Nordberg A. Differential changes of nicotinic receptors in the rat brain following ibotenic acid and 192-IgG saporin lesions of the nucleus basalis magnocellularis. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 661-8. PMID 10198814 DOI: 10.1016/S0736-5748(98)00076-8  0.302
1998 Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Drug Safety. 19: 465-80. PMID 9880090 DOI: 10.2165/00002018-199819060-00004  0.338
1998 Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neuroscience Letters. 254: 85-8. PMID 9779926 DOI: 10.1016/S0304-3940(98)00669-7  0.579
1998 Lundqvist H, Nordberg A, Hartvig P, LÃ¥ngström B. (S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain. Alzheimer Disease and Associated Disorders. 12: 238-46. PMID 9772029 DOI: 10.1097/00002093-199809000-00018  0.387
1998 Nordberg A, Amberla K, Shigeta M, Lundqvist H, Viitanen M, Hellström-Lindahl E, Johansson M, Andersson J, Hartvig P, Lilja A, LÃ¥ngström B, Winblad B. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Disease and Associated Disorders. 12: 228-37. PMID 9772028 DOI: 10.1097/00002093-199809000-00017  0.372
1998 Sihver W, Fasth KJ, Ogren M, Bivehed H, Bergström M, Nordberg A, Watanabe Y, Långström B. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies. Journal of Neurochemistry. 71: 1750-60. PMID 9751211 DOI: 10.1046/J.1471-4159.1998.71041750.X  0.311
1998 Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 9: 246-57. PMID 9701676 DOI: 10.1159/000017069  0.333
1997 Bäckman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, Långström B. Brain activation in young and older adults during implicit and explicit retrieval. Journal of Cognitive Neuroscience. 9: 378-91. PMID 23965013 DOI: 10.1162/Jocn.1997.9.3.378  0.499
1997 Hartvig P, Torstenson R, Bjurling P, Fasth KJ, Längström B, Nordberg A. Regional brain distribution and binding of the muscarinic receptor agonist CI-979 studied by positron emission tomography in the monkey. Dementia and Geriatric Cognitive Disorders. 8: 259-66. PMID 9298626 DOI: 10.1159/000106642  0.303
1997 Svensson AL, Warpman U, Hellström-Lindahl E, Bogdanovic N, Lannfelt L, Nordberg A. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes. Neuroscience Letters. 232: 37-40. PMID 9292886 DOI: 10.1016/S0304-3940(97)00573-9  0.421
1997 Lundqvist H, LÃ¥ngström B, Nordberg A. Use of carbon-11 nicotine in PET studies. European Journal of Nuclear Medicine. 24: 825-6. PMID 9289404 DOI: 10.1007/Bf00879673  0.317
1997 Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 59-65. PMID 9221969 DOI: 10.1136/Jnnp.63.1.59  0.386
1997 Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, Nordberg A. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Archives of Neurology. 54: 273-7. PMID 9074396 DOI: 10.1001/Archneur.1997.00550150035013  0.438
1997 Nordberg A, Lundqvist H, Hartvig P, Andersson J, Johansson M, Hellstrŏm-Lindahi E, LÃ¥ngström B. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. Dementia and Geriatric Cognitive Disorders. 8: 78-84. PMID 9065319 DOI: 10.1159/000106611  0.414
1996 Algotsson A, Nordberg A, Lannfelt L, Almkvist O, Winblad B. Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease. Archives of Gerontology and Geriatrics. 22: 223-32. PMID 15374172 DOI: 10.1016/0167-4943(96)00695-4  0.572
1996 Nordberg A. Pharmacological treatment of cognitive dysfunction in dementia disorders. Acta Neurologica Scandinavica. Supplementum. 168: 87-92. PMID 8997426 DOI: 10.1111/J.1600-0404.1996.Tb00379.X  0.374
1996 Nordberg A. Application of PET in dementia disorders. Acta Neurologica Scandinavica. Supplementum. 168: 71-6. PMID 8997424 DOI: 10.1111/J.1600-0404.1996.Tb00377.X  0.49
1996 Johansson M, Hellström-Lindahl E, Nordberg A. Steady-state pharmacokinetics of tacrine in long-term treatment of Alzheimer patients. Dementia (Basel, Switzerland). 7: 111-7. PMID 8866685 DOI: 10.1159/000106863  0.301
1996 Nordberg A. Functional studies of new drugs for the treatment of Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum. 165: 137-44. PMID 8741001 DOI: 10.1111/J.1600-0404.1996.Tb05884.X  0.435
1996 Lunell E, Bergström M, Antoni G, LÃ¥ngström B, Nordberg A. Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clinical Pharmacology and Therapeutics. 59: 593-4. PMID 8646831 DOI: 10.1016/S0009-9236(96)90188-5  0.306
1996 Warpman U, Marude A, Hellström-Lindahl E, Lannfelt L, Nordberg A. 721 Neuronal nicotinic receptor impairment and APOE polymorphism in Alzheimer's disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80723-8  0.377
1996 Jönhagen M, Wahlund LO, Amberla K, Ebendal T, Meyersson B, Nordberg A, Olson L, Shigeta M, Seiger Å, Viitanen M, Winblad B. 645 Nerve Growth Factors as a Treatment of Alzheimer's Disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80647-6  0.325
1996 Jelic V, Almkvist O, Julin P, Wahlund L, Winblad B, Nordberg A. 367 Patterns of brain metabolism in patients with mild cognitive impairment Neurobiology of Aging. 17: S92. DOI: 10.1016/S0197-4580(96)80369-1  0.552
1995 Warpman U, Nordberg A. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Neuroreport. 6: 2419-23. PMID 8747166 DOI: 10.1097/00001756-199511270-00033  0.338
1995 Algotsson A, Nordberg A, Almkvist O, Winblad B. Skin vessel reactivity is impaired in Alzheimer's disease. Neurobiology of Aging. 16: 577-82. PMID 8544908 DOI: 10.1016/0197-4580(95)00077-R  0.587
1995 James JR, Nordberg A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behavior Genetics. 25: 149-59. PMID 7733856 DOI: 10.1007/Bf02196924  0.35
1995 Nordberg A, Lundqvist H, Hartvig P, Lilja A, LÃ¥ngström B. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography. Alzheimer Disease and Associated Disorders. 9: 21-7. PMID 7605618 DOI: 10.1097/00002093-199505000-00006  0.429
1994 Nordberg A. Human nicotinic receptors--their role in aging and dementia. Neurochemistry International. 25: 93-7. PMID 7950977 DOI: 10.1016/0197-0186(94)90059-0  0.395
1993 Warpman U, Alafuzoff I, Nordberg A. Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease. Neuroscience Letters. 150: 39-43. PMID 8469400 DOI: 10.1016/0304-3940(93)90103-R  0.37
1993 Nordberg A. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET. Acta Neurologica Scandinavica. Supplementum. 149: 62-5. PMID 8128843 DOI: 10.1111/J.1600-0404.1993.Tb04259.X  0.446
1993 Amberla K, Nordberg A, Viitanen M, Winblad B. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data. Acta Neurologica Scandinavica. Supplementum. 149: 55-7. PMID 8128841 DOI: 10.1111/J.1600-0404.1993.Tb04257.X  0.363
1993 Seiger A, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behavioural Brain Research. 57: 255-61. PMID 8117429 DOI: 10.1016/0166-4328(93)90141-C  0.393
1993 Nordberg A. Clinical studies in Alzheimer patients with positron emission tomography. Behavioural Brain Research. 57: 215-24. PMID 7906947 DOI: 10.1016/0166-4328(93)90138-G  0.534
1993 Nordberg A. In vivo detection of neurotransmitter changes in Alzheimer's disease. Annals of the New York Academy of Sciences. 695: 27-33. PMID 7902055 DOI: 10.1111/J.1749-6632.1993.Tb23022.X  0.515
1993 Nordberg A, Hartvig P, Andersson J, Lundqvist H, Vittanen M, Långström B, Winblad B. Visualization of muscarinic receptors in Alzheimer brains in vivo by positron emission tomography Life Sciences. 52: 556. DOI: 10.1016/0024-3205(93)90329-2  0.385
1993 Svensson A, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in normal and Alzheimer brain tissue by using selective muscarinic antagonists Life Sciences. 52: 556. DOI: 10.1016/0024-3205(93)90328-Z  0.321
1992 Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. Journal of Neuroscience Research. 31: 103-11. PMID 1613816 DOI: 10.1002/Jnr.490310115  0.327
1992 Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M, Warpman U, Johansson M, Hellström-Lindahl E, Bjurling P. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiology of Aging. 13: 747-58. PMID 1491741 DOI: 10.1016/0197-4580(92)90099-J  0.464
1992 Svensson AL, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Brain Research. 596: 142-8. PMID 1467980 DOI: 10.1016/0006-8993(92)91541-L  0.322
1992 Svensson A, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer brains Neurobiology of Aging. 13: S132. DOI: 10.1016/0197-4580(92)90649-I  0.358
1992 Warpman U, Alafuzoff I, Nordberg A. Defect coupling of muscarinic receptors to GTP-proteins in Alzheimer brains Neurobiology of Aging. 13: S61. DOI: 10.1016/0197-4580(92)90368-8  0.316
1991 Nordberg A, Hartvig P, Lilja A, Viitanen M, Amberla K, Lundqvist H, Andersson J, Nybäck H, Ulin J, Anderson Y. Nicotine receptors in the brain of patients with Alzheimer's disease. Studies with 11C-nicotine and positron emission tomography. Acta Radiologica. Supplementum. 376: 165-6. PMID 1666767  0.305
1990 Nordberg A, Adem A, Nilsson-HÃ¥kansson L, Bucht G, Hartvig P, Alafuzoff I, Viitanen M, LÃ¥ngström B, Winblad B. New approaches to clinical and postmortem investigations of cholinergic mechanisms. Progress in Brain Research. 84: 313-20. PMID 2267305 DOI: 10.1016/S0079-6123(08)60915-2  0.332
1990 Nordberg A. Pharmacological modulation of transmitter activity in Alzheimer brains--an experimental model. Acta Neurologica Scandinavica. Supplementum. 129: 17-20. PMID 1977274 DOI: 10.1111/J.1600-0404.1990.Tb02597.X  0.335
1990 Sakurada T, Alufuzoff I, Winblad B, Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Research. 521: 329-32. PMID 1698512 DOI: 10.1016/0006-8993(90)91561-T  0.448
1989 Nordberg A, Nilsson-HÃ¥kansson L, Adem A, Hardy J, Alafuzoff I, Lai Z, Herrera-Marschitz M, Winblad B. The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. Progress in Brain Research. 79: 353-62. PMID 2685906 DOI: 10.1016/S0079-6123(08)62495-4  0.339
1988 Nordberg A, Adem A, Hardy J, Winblad B. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains Neuroscience Letters. 86: 317-321. PMID 3380323 DOI: 10.1016/0304-3940(88)90503-4  0.363
1987 Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? Journal of Neural Transmission. 70: 357-368. PMID 3681290 DOI: 10.1007/Bf01253610  0.311
1987 Nordberg A, Nyberg P, Adolfsson R, Winblad B. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile. Journal of Neural Transmission. 69: 19-32. PMID 3585318 DOI: 10.1007/Bf01244094  0.41
1986 Adem A, Nordberg A, Bucht G, Winblad B. Extraneural cholinergic markers in Alzheimer's and Parkinson's disease Progress in Neuropsychopharmacology and Biological Psychiatry. 10: 247-257. PMID 3797683 DOI: 10.1016/0278-5846(86)90005-9  0.419
1986 Nordberg A, Alafuzoff I, Winblad B. Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type. Neuroscience Letters. 70: 160-4. PMID 3774212 DOI: 10.1016/0304-3940(86)90456-8  0.412
1985 Nyberg P, Adolfsson R, Hardy JA, Nordberg A, Wester P, Winblad B. Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains. Brain Research. 333: 139-42. PMID 3995281 DOI: 10.1016/0006-8993(85)90133-7  0.357
1983 Gottfries C, Adolfsson R, Aquilonius S, Carlsson A, Eckernas S, Nordberg A, Oreland L, Svennerholm L, Wiberg Å, Winblad B. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiology of Aging. 4: 261-271. PMID 6200784 DOI: 10.1016/0197-4580(83)90002-7  0.442
1983 Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B. Muscarinic receptor compensation in hippocampus of Alzheimer patients. Journal of Neural Transmission. 56: 13-9. PMID 6133910 DOI: 10.1007/Bf01243370  0.335
Show low-probability matches.